Biogen Net Invested Capital vs Treasury Stock Analysis

BIIB Stock

USD 137.33 1.12 0.81%

Biogen financial indicator trend analysis is way more than just evaluating Biogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biogen Inc is a good investment. Please check the relationship between Biogen Net Invested Capital and its Treasury Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Net Invested Capital vs Treasury Stock

Net Invested Capital vs Treasury Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biogen Inc Net Invested Capital account and Treasury Stock. At this time, the significance of the direction appears to have no relationship.

The correlation between Biogen's Net Invested Capital and Treasury Stock is 0.08. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Treasury Stock in the same time period over historical financial statements of Biogen Inc, assuming nothing else is changed. The correlation between historical values of Biogen's Net Invested Capital and Treasury Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Biogen Inc are associated (or correlated) with its Treasury Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Treasury Stock has no effect on the direction of Net Invested Capital i.e., Biogen's Net Invested Capital and Treasury Stock go up and down completely randomly.

Correlation Coefficient

0.08

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Treasury Stock

Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 17.39, whereas Tax Provision is forecasted to decline to about 260.1 M.

	2022	2023	2024	2025 (projected)
Gross Profit	7.9B	7.3B	9.7B	10.2B
Total Revenue	10.2B	9.8B	9.7B	10.2B

Gross Profit Total Revenue

Biogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Common Stock	Short Term Debt
Total Assets		0.91	0.96	0.93	0.94	0.96	0.82	0.98	0.77	0.99	-0.58	0.57	0.77	-0.74	0.79	0.5	-0.81	0.95	0.87	0.93	0.62	0.89	-0.79	0.16	-0.79	0.56
Short Long Term Debt Total	0.91		0.87	0.81	0.73	0.89	0.96	0.89	0.7	0.88	-0.73	0.6	0.76	-0.66	0.9	0.43	-0.92	0.97	0.76	0.89	0.43	0.84	-0.63	0.28	-0.63	0.41
Other Current Liab	0.96	0.87		0.87	0.86	0.89	0.78	0.94	0.74	0.93	-0.59	0.66	0.79	-0.69	0.82	0.49	-0.81	0.94	0.72	0.92	0.5	0.83	-0.76	0.33	-0.76	0.47
Total Current Liabilities	0.93	0.81	0.87		0.9	0.87	0.69	0.92	0.79	0.94	-0.52	0.44	0.56	-0.61	0.6	0.35	-0.71	0.85	0.88	0.81	0.7	0.86	-0.69	-0.03	-0.69	0.74
Total Stockholder Equity	0.94	0.73	0.86	0.9		0.86	0.62	0.95	0.73	0.94	-0.39	0.41	0.61	-0.7	0.55	0.51	-0.61	0.78	0.9	0.84	0.77	0.78	-0.81	-0.02	-0.81	0.58
Property Plant And Equipment Net	0.96	0.89	0.89	0.87	0.86		0.81	0.91	0.72	0.95	-0.51	0.54	0.84	-0.81	0.81	0.45	-0.75	0.94	0.85	0.88	0.48	0.95	-0.78	0.15	-0.78	0.54
Net Debt	0.82	0.96	0.78	0.69	0.62	0.81		0.79	0.47	0.81	-0.71	0.45	0.72	-0.59	0.89	0.36	-0.88	0.91	0.7	0.75	0.41	0.72	-0.55	0.26	-0.55	0.32
Retained Earnings	0.98	0.89	0.94	0.92	0.95	0.91	0.79		0.78	0.97	-0.62	0.53	0.71	-0.67	0.73	0.47	-0.83	0.91	0.88	0.92	0.67	0.83	-0.72	0.11	-0.72	0.56
Cash	0.77	0.7	0.74	0.79	0.73	0.72	0.47	0.78		0.69	-0.49	0.74	0.55	-0.56	0.56	0.42	-0.67	0.72	0.58	0.87	0.31	0.79	-0.56	0.2	-0.56	0.47
Non Current Assets Total	0.99	0.88	0.93	0.94	0.94	0.95	0.81	0.97	0.69		-0.56	0.44	0.72	-0.71	0.74	0.45	-0.77	0.92	0.92	0.86	0.7	0.86	-0.76	0.04	-0.76	0.62
Non Currrent Assets Other	-0.58	-0.73	-0.59	-0.52	-0.39	-0.51	-0.71	-0.62	-0.49	-0.56		-0.37	-0.46	0.17	-0.66	-0.15	0.87	-0.69	-0.47	-0.56	-0.29	-0.49	0.08	-0.14	0.08	-0.28
Cash And Short Term Investments	0.57	0.6	0.66	0.44	0.41	0.54	0.45	0.53	0.74	0.44	-0.37		0.65	-0.56	0.71	0.47	-0.6	0.64	0.14	0.81	-0.16	0.6	-0.55	0.79	-0.55	0.12
Net Receivables	0.77	0.76	0.79	0.56	0.61	0.84	0.72	0.71	0.55	0.72	-0.46	0.65		-0.84	0.91	0.34	-0.72	0.83	0.52	0.8	0.13	0.81	-0.64	0.38	-0.64	0.13
Common Stock Shares Outstanding	-0.74	-0.66	-0.69	-0.61	-0.7	-0.81	-0.59	-0.67	-0.56	-0.71	0.17	-0.56	-0.84		-0.72	-0.46	0.45	-0.71	-0.6	-0.74	-0.31	-0.79	0.85	-0.22	0.85	-0.22
Non Current Liabilities Total	0.79	0.9	0.82	0.6	0.55	0.81	0.89	0.73	0.56	0.74	-0.66	0.71	0.91	-0.72		0.39	-0.87	0.92	0.51	0.82	0.13	0.77	-0.57	0.51	-0.57	0.22
Other Current Assets	0.5	0.43	0.49	0.35	0.51	0.45	0.36	0.47	0.42	0.45	-0.15	0.47	0.34	-0.46	0.39		-0.26	0.43	0.38	0.55	0.25	0.38	-0.61	0.33	-0.61	0.11
Other Stockholder Equity	-0.81	-0.92	-0.81	-0.71	-0.61	-0.75	-0.88	-0.83	-0.67	-0.77	0.87	-0.6	-0.72	0.45	-0.87	-0.26		-0.91	-0.61	-0.82	-0.31	-0.72	0.37	-0.31	0.37	-0.38
Total Liab	0.95	0.97	0.94	0.85	0.78	0.94	0.91	0.91	0.72	0.92	-0.69	0.64	0.83	-0.71	0.92	0.43	-0.91		0.75	0.91	0.42	0.89	-0.69	0.31	-0.69	0.48
Property Plant And Equipment Gross	0.87	0.76	0.72	0.88	0.9	0.85	0.7	0.88	0.58	0.92	-0.47	0.14	0.52	-0.6	0.51	0.38	-0.61	0.75		0.67	0.83	0.75	-0.63	-0.3	-0.63	0.65
Total Current Assets	0.93	0.89	0.92	0.81	0.84	0.88	0.75	0.92	0.87	0.86	-0.56	0.81	0.8	-0.74	0.82	0.55	-0.82	0.91	0.67		0.38	0.86	-0.77	0.41	-0.77	0.39
Intangible Assets	0.62	0.43	0.5	0.7	0.77	0.48	0.41	0.67	0.31	0.7	-0.29	-0.16	0.13	-0.31	0.13	0.25	-0.31	0.42	0.83	0.38		0.36	-0.48	-0.49	-0.48	0.52
Accounts Payable	0.89	0.84	0.83	0.86	0.78	0.95	0.72	0.83	0.79	0.86	-0.49	0.6	0.81	-0.79	0.77	0.38	-0.72	0.89	0.75	0.86	0.36		-0.72	0.16	-0.72	0.54
Common Stock Total Equity	-0.79	-0.63	-0.76	-0.69	-0.81	-0.78	-0.55	-0.72	-0.56	-0.76	0.08	-0.55	-0.64	0.85	-0.57	-0.61	0.37	-0.69	-0.63	-0.77	-0.48	-0.72		-0.3	1.0	-0.32
Short Term Investments	0.16	0.28	0.33	-0.03	-0.02	0.15	0.26	0.11	0.2	0.04	-0.14	0.79	0.38	-0.22	0.51	0.33	-0.31	0.31	-0.3	0.41	-0.49	0.16	-0.3		-0.3	-0.19
Common Stock	-0.79	-0.63	-0.76	-0.69	-0.81	-0.78	-0.55	-0.72	-0.56	-0.76	0.08	-0.55	-0.64	0.85	-0.57	-0.61	0.37	-0.69	-0.63	-0.77	-0.48	-0.72	1.0	-0.3		-0.32
Short Term Debt	0.56	0.41	0.47	0.74	0.58	0.54	0.32	0.56	0.47	0.62	-0.28	0.12	0.13	-0.22	0.22	0.11	-0.38	0.48	0.65	0.39	0.52	0.54	-0.32	-0.19	-0.32

Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.6B	23.9B	24.6B	26.8B	28.0B	29.5B
Short Long Term Debt Total	7.8B	7.6B	6.6B	7.3B	6.6B	7.0B
Other Current Liab	3.1B	2.4B	2.4B	2.5B	2.8B	2.9B
Total Current Liabilities	3.7B	4.3B	3.3B	3.4B	5.5B	5.8B
Total Stockholder Equity	10.7B	11.0B	13.4B	14.8B	16.7B	17.6B
Property Plant And Equipment Net	3.8B	3.8B	3.7B	3.7B	3.5B	3.7B
Net Debt	6.5B	5.3B	3.2B	6.3B	4.3B	4.5B
Retained Earnings	14.0B	13.9B	16.5B	17.6B	19.3B	20.2B
Cash	1.3B	2.3B	3.4B	1.0B	2.4B	2.5B
Non Current Assets Total	17.7B	16.0B	14.8B	20.0B	20.6B	21.6B
Non Currrent Assets Other	(1.4B)	1.9B	1.5B	284.3M	560.5M	532.5M
Cash And Short Term Investments	2.6B	3.8B	4.9B	1.0B	2.4B	1.5B
Net Receivables	2.3B	2.0B	2.1B	2.1B	1.4B	743.7M
Common Stock Shares Outstanding	161.3M	149.6M	146M	145.6M	145.9M	278.8M
Liabilities And Stockholders Equity	24.6B	23.9B	24.6B	26.8B	28.0B	29.5B
Non Current Liabilities Total	10.2B	8.6B	7.9B	8.6B	5.8B	3.2B
Other Current Assets	881.1M	740.8M	1.4B	1.2B	1.2B	1.3B
Other Stockholder Equity	(3.0B)	(2.9B)	(2.9B)	(2.7B)	(2.4B)	(2.3B)
Total Liab	13.9B	12.9B	11.2B	12.0B	11.3B	11.9B
Property Plant And Equipment Gross	3.8B	3.8B	3.7B	6.1B	6.2B	6.5B
Total Current Assets	6.9B	7.9B	9.8B	6.9B	7.5B	7.8B
Accumulated Other Comprehensive Income	(299M)	(106.7M)	(164.9M)	(153.7M)	(136.2M)	(129.4M)
Intangible Assets	3.1B	2.2B	1.9B	8.4B	9.7B	10.2B
Accounts Payable	454.9M	589.2M	491.5M	403.3M	424.2M	445.4M
Short Term Investments	2.3B	1.6B	1.3B	1.5B	1.5B	0.0
Short Term Debt	83.2M	1.1B	97.2M	240.3M	1.7B	1.8B
Inventory	1.1B	1.4B	1.3B	2.5B	2.5B	2.6B
Other Liab	4.2B	2.4B	2.0B	1.3B	1.5B	969.6M
Other Assets	3.2B	4.2B	3.4B	1.7B	1.9B	2.0B
Long Term Debt	7.4B	6.3B	6.3B	6.8B	4.5B	3.0B
Property Plant Equipment	3.2B	3.4B	3.4B	3.3B	3.8B	2.1B
Current Deferred Revenue	(83.2M)	(589.2M)	(97.2M)	3M	2.7M	2.8M
Good Will	5.8B	5.8B	5.7B	6.2B	6.5B	3.3B
Net Tangible Assets	4.1B	1.9B	2.9B	5.8B	6.7B	4.1B
Noncontrolling Interest In Consolidated Entity	(4.1M)	(14.2M)	63.5M	(9.5M)	(8.6M)	(8.1M)
Retained Earnings Total Equity	16.5B	14.0B	13.9B	16.5B	18.9B	11.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.063

Earnings Share

11.18

Revenue Per Share

66.455

Quarterly Revenue Growth

0.029

Return On Assets

0.0529

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Net Invested Capital vs Treasury Stock Analysis

Net Invested Capital vs Treasury Stock

Net Invested Capital vs Treasury Stock Correlation Analysis

Correlation Coefficient

Net Invested Capital

Treasury Stock

Biogen fundamental ratios Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Non Current Assets Total	+ 0.99	Total Assets
Retained Earnings	+ 0.98	Total Assets
Total Liab	+ 0.97	Short Long Term Debt Total
Non Current Assets Total	+ 0.97	Retained Earnings
Other Current Liab	+ 0.96	Total Assets

Other Stockholder Equity	- 0.92	Short Long Term Debt Total
Total Liab	- 0.91	Other Stockholder Equity
Other Stockholder Equity	- 0.88	Net Debt
Other Stockholder Equity	- 0.87	Non Current Liabilities Total
Common Stock Shares Outstanding	- 0.84	Net Receivables
Other Stockholder Equity	- 0.83	Retained Earnings